scispace - formally typeset
A

Alan M. Pittman

Researcher at UCL Institute of Neurology

Publications -  103
Citations -  9877

Alan M. Pittman is an academic researcher from UCL Institute of Neurology. The author has contributed to research in topics: Genome-wide association study & Progressive supranuclear palsy. The author has an hindex of 43, co-authored 95 publications receiving 8852 citations. Previous affiliations of Alan M. Pittman include University College London.

Papers
More filters
Journal ArticleDOI

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

TL;DR: It is proposed that PSP-P represents a second discrete clinical phenotype that needs to be clinically distinguished from classical PSP (RS), and the different tau isoform deposition in the basal pons suggests that this may ultimately prove to be a discrete nosological entity.
Journal ArticleDOI

Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer

TL;DR: Four previously unreported CRC risk loci are identified at 14q22.2, highlighting the value of large sample series for discovery and follow-up of genetic variants contributing to the etiology of CRC.
Journal ArticleDOI

A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3

Ian Tomlinson, +79 more
- 01 May 2008 - 
TL;DR: Genetic data provide further evidence for the 'common-disease common-variant' model of CRC predisposition and identify two previously unreported associations.
Journal ArticleDOI

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Wouter van Rheenen, +187 more
- 01 Sep 2016 - 
TL;DR: Evidence of ALS being a complex genetic trait with a polygenic architecture is established and the SNP-based heritability is estimated at 8.5%, with a distinct and important role for low-frequency variants (frequency 1–10%).